Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biomarkers

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/13547500902767294PMID 19330589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population.

  2008influential reference
• Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.

  2006influential reference
• Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.

  2006influential reference
• Selected Genetic Polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and Risk of Head and Neck Cancer: A Pooled Analysis

  2005influential reference
• Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.

  2005influential reference
• CYP2D6 and CYP1A1 mutations in the Turkish population

  2005influential reference
• Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population

  2005influential reference
• Genetic polymorphisms in the Hmong population

  2004influential reference
• Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.

  2004influential reference
• Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples

  2003influential reference
• NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia.

  2003influential reference
• CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China.

  2003cited by this paper
• Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype.

  2003cited by this paper
• CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

  2002cited by this paper
• CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

  2002cited by this paper
• Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

  2002cited by this paper
• Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.

  2001influential reference
• Recent advances in P450 research

  2001cited by this paper
• Association between genetic polymorphisms and biomarkers in styrene-exposed workers.

  2001cited by this paper
• The phylogeography of Brazilian Y-chromosome lineages.

  2001cited by this paper
• Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.

  2001cited by this paper
• Epoxide hydrolases: biochemistry and molecular biology.

  2000cited by this paper
• The ancestry of Brazilian mtDNA lineages.

  2000cited by this paper
• Drug metabolism polymorphisms as modulators of cancer susceptibility.

  1999cited by this paper
• A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators.

  1999cited by this paper
• Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.

  1999cited by this paper
• The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1.

  1998cited by this paper
• CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.

  1998influential reference
• Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication.

  1998cited by this paper
• Prevalence of homozygosity for the deleted alleles of glutathione S‐transferase mu (GSTMl) and theta (GSTTl) among distinct ethnic groutx from Brazil: relevance to enviromental carcinogenesis?

  1998influential reference
• Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression.

  1997cited by this paper
• Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.

  1997influential reference
• Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.

  1997cited by this paper
• Molecular mechanisms of genetic polymorphisms of drug metabolism.

  1997influential reference
• Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

  1997cited by this paper
• Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

  1997influential reference
• Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer

  1996cited by this paper
• Genetic metabolic polymorphisms and the risk of cancer: a review of the literature.

  1996cited by this paper
• Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research.

  1995cited by this paper
• Cancer among Hispanic males in south Florida. Nine years of incidence data.

  1994cited by this paper
• Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.

  1992cited by this paper
• Socioeconomic factors and cancer incidence among blacks and whites.

  1991cited by this paper
• Identification of the primary gene defect at the cytochrome P450 CYP2D locus

  1990cited by this paper

• Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.

  2024cites this paper
• Frequency of CYP2D6*3 and *4 and metabolizer phenotypes in three mestizo Peruvian populations

  2021cites this paper
• CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region

  2021cites this paper
• Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics

  2018influential citation
• Pharmacogenetics in Central American healthy volunteers: interethnic variability

  2015cites this paper
• Farmacogenética del "CYP2D6" en la población argentina general y judía Ashkenazi

  2015cites this paper
• Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population

  2014cites this paper
• Determination of CYP2D6 *3, *4, and *10 frequency in women with breast cancer in São Luís, Brazil, and its association with prognostic factors and disease-free survival

  2014cites this paper
• Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.

  2014cites this paper
• Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations

  2014cites this paper
• CYP2D6 ethnic variability in Hispanics

  2014cites this paper
• Metoprolol oxidation polymorphism in Brazilian elderly cardiac patients

  2013cites this paper
• Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an Indian population perspective

  2010cites this paper